Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,989 | 0 | 0 | 0 | 0 |
| Cost of Goods | 2,374 | N/A | N/A | N/A | N/A |
| Gross Profit | 1,615 | N/A | N/A | N/A | N/A |
| Operating Expenses | 30,136 | 29,002 | 33,902 | 32,728 | 29,591 |
| Operating Income | -28,147 | -29,002 | -33,902 | -32,728 | -29,591 |
| Other Income | 172 | 646 | 897 | 1,048 | 610 |
| Pre-tax Income | -27,975 | -28,356 | -33,005 | -31,680 | -28,981 |
| Net Income Continuous | -27,975 | -28,356 | -33,005 | -31,680 | -28,981 |
| Net Income | $-27,975 | $-28,356 | $-33,005 | $-31,680 | $-28,981 |
| EPS Basic Total Ops | -3,863.00 | -4,923.00 | -10,255.59 | 6,174.12 | -13,546.33 |
| EPS Basic Continuous Ops | -3,862.94 | -4,922.52 | -10,269.01 | 5,948.63 | -13,530.57 |
| EPS Diluted Total Ops | -3,863.00 | -4,923.00 | -10,255.59 | 6,174.12 | -13,546.33 |
| EPS Diluted Continuous Ops | -3,862.94 | -4,922.52 | -10,269.01 | 5,948.63 | -13,530.57 |
| EBITDA(a) | $-26,931 | $-28,081 | $-33,009 | $-31,892 | $-29,339 |